(Q36577423)

15 August 2017

1 reference

title

Mechanisms of disease: atherosclerosis in autoimmune diseases (English)

1 reference

15 August 2017

1 reference

2

Yehuda Shoenfeld

1 reference

15 August 2017

1

Yaniv Sherer

1 reference

15 August 2017

1 February 2006

1 reference

Nature Clinical Practice Rheumatology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

2

1 reference

15 August 2017

99-106

1 reference

Inflammation, atherosclerosis, and coronary artery disease

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Immunology of ischemic vascular disease: plaque to attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Accelerated atherosclerosis in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Immunomodulation of various autoimmune diseases by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Immunomodulation for treatment and prevention of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

Artherosclerosis as an infectious, inflammatory and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

New evidence for vascular disease in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Cardiovascular death in rheumatoid arthritis: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0092

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0092

1 reference

15 August 2017

1 reference

PubMed ID

16932663